Stock listing
NASDAQ:CELZ Creative Medical Technology Holdings, Inc. Stock
Home listing (NASDAQ) of Creative Medical Technology Holdings, Inc.
Follow Creative Medical Technology Holdings, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:CELZ
$0.624 USD -0.031 (-4.8%)
Close on Nov 2, 2026
- Day range
- $0.601 – $0.674 USDNov 2, 2026
- Volume
- 224,680 sharesNov 2, 2026
- Market cap
- $4.73M USDAt the close on Nov 2, 2026 · price × 7.59M shares outstanding
- 52-week range
- $0.601 – $4.720 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $7.54M USDMedian day 173,100 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:CELZ · Home | $0.624 USD | -0.031 (-4.8%) | 224,680 | $0.650 | $0.674 | $0.601 | $0.655 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:CELZ · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.624 | -0.031 | -4.8% | $0.650 | $0.674 | $0.601 | 224,680 | |
| $0.655 | -0.023 | -3.4% | $0.719 | $0.719 | $0.655 | 86,506 | |
| $0.678 | -0.042 | -5.8% | $0.723 | $0.738 | $0.678 | 62,355 | |
| $0.720 | +0.030 | +4.3% | $0.693 | $0.720 | $0.672 | 90,483 | |
| $0.690 | -0.022 | -3.1% | $0.735 | $0.735 | $0.681 | 142,117 | |
| $0.712 | -0.028 | -3.8% | $0.765 | $0.765 | $0.710 | 44,896 | |
| $0.740 | -0.034 | -4.4% | $0.765 | $0.768 | $0.731 | 24,500 | |
| $0.774 | +0.032 | +4.3% | $0.754 | $0.780 | $0.740 | 46,000 | |
| $0.742 | -0.012 | -1.6% | $0.750 | $0.765 | $0.730 | 50,700 | |
| $0.755 | +0.031 | +4.3% | $0.702 | $0.780 | $0.680 | 404,900 | |
| $0.724 | -0.017 | -2.3% | $0.747 | $0.747 | $0.722 | 95,400 | |
| $0.741 | -0.077 | -9.4% | $0.839 | $0.849 | $0.734 | 168,800 | |
| $0.818 | +0.045 | +5.9% | $0.780 | $0.821 | $0.763 | 63,100 | |
| $0.772 | -0.048 | -5.8% | $0.800 | $0.800 | $0.757 | 167,400 | |
| $0.820 | -0.021 | -2.5% | $0.830 | $0.850 | $0.810 | 56,900 | |
| $0.841 | +0.002 | +0.3% | $0.830 | $0.869 | $0.822 | 90,100 | |
| $0.839 | -0.022 | -2.5% | $0.860 | $0.880 | $0.820 | 148,800 | |
| $0.860 | -0.029 | -3.2% | $0.880 | $0.893 | $0.860 | 40,300 | |
| $0.889 | -0.011 | -1.3% | $0.910 | $0.910 | $0.880 | 52,200 | |
| $0.900 | -0.020 | -2.1% | $0.900 | $0.918 | $0.890 | 70,100 | |
| $0.920 | -0.026 | -2.8% | $0.960 | $0.960 | $0.920 | 70,900 | |
| $0.946 | +0.005 | +0.5% | $0.940 | $0.970 | $0.915 | 89,500 | |
| $0.942 | +0.007 | +0.8% | $0.930 | $0.970 | $0.930 | 208,300 | |
| $0.935 | -0.031 | -3.2% | $0.930 | $0.980 | $0.882 | 98,100 | |
| $0.965 | -0.045 | -4.4% | $1.000 | $1.011 | $0.910 | 234,800 | |
| $1.010 | -0.020 | -1.9% | $1.000 | $1.040 | $0.980 | 213,800 | |
| $1.030 | +0.060 | +6.2% | $0.990 | $1.050 | $0.942 | 321,500 | |
| $0.970 | -0.004 | -0.4% | $0.948 | $0.990 | $0.920 | 200,700 | |
| $0.974 | +0.034 | +3.6% | $0.891 | $1.000 | $0.891 | 361,200 | |
| $0.940 | -0.065 | -6.5% | $0.880 | $0.960 | $0.800 | 1,778,700 | |
| $1.005 | +0.039 | +4.0% | $0.993 | $1.040 | $0.947 | 20,008,800 | |
| $0.966 | +0.088 | +10.1% | $0.889 | $0.966 | $0.874 | 167,800 | |
| $0.878 | +0.055 | +6.8% | $0.860 | $0.897 | $0.829 | 180,000 | |
| $0.822 | -0.063 | -7.1% | $0.894 | $0.900 | $0.821 | 146,600 | |
| $0.885 | +0.007 | +0.8% | $0.917 | $0.972 | $0.850 | 118,800 | |
| $0.878 | -0.083 | -8.6% | $0.951 | $0.973 | $0.856 | 404,200 | |
| $0.961 | +0.010 | +1.1% | $0.950 | $0.998 | $0.950 | 99,700 | |
| $0.950 | -0.090 | -8.6% | $1.050 | $1.056 | $0.936 | 320,300 | |
| $1.040 | -0.040 | -3.7% | $1.080 | $1.085 | $1.040 | 109,000 | |
| $1.080 | -0.030 | -2.7% | $1.100 | $1.120 | $1.070 | 140,500 | |
| $1.110 | +0.050 | +4.7% | $1.060 | $1.120 | $1.060 | 151,200 | |
| $1.060 | -0.070 | -6.2% | $1.140 | $1.140 | $1.040 | 173,100 | |
| $1.130 | +0.030 | +2.7% | $1.100 | $1.150 | $1.100 | 94,100 | |
| $1.100 | -0.030 | -2.7% | $1.110 | $1.130 | $1.090 | 104,900 | |
| $1.130 | -0.010 | -0.9% | $1.140 | $1.190 | $1.090 | 243,200 | |
| $1.140 | 0.000 | 0.0% | $1.170 | $1.180 | $1.115 | 197,500 | |
| $1.140 | -0.050 | -4.2% | $1.200 | $1.210 | $1.120 | 248,900 | |
| $1.190 | -0.050 | -4.0% | $1.220 | $1.250 | $1.190 | 249,100 | |
| $1.240 | +0.030 | +2.5% | $1.190 | $1.260 | $1.190 | 171,193 | |
| $1.210 | -0.100 | -7.6% | $1.290 | $1.290 | $1.190 | 387,166 | |
| $1.310 | +0.030 | +2.3% | $1.270 | $1.350 | $1.220 | 545,100 | |
| $1.280 | +0.160 | +14.3% | $1.280 | $1.430 | $1.080 | 10,263,400 | |
| $1.120 | +0.040 | +3.7% | $1.080 | $1.170 | $1.080 | 605,000 | |
| $1.080 | -0.020 | -1.8% | $1.070 | $1.130 | $1.060 | 314,900 | |
| $1.100 | -0.120 | -9.8% | $1.180 | $1.180 | $1.090 | 443,100 | |
| $1.220 | -0.020 | -1.6% | $1.220 | $1.280 | $1.190 | 679,100 | |
| $1.240 | +0.040 | +3.3% | $1.230 | $1.250 | $1.180 | 816,900 | |
| $1.200 | -0.040 | -3.2% | $1.240 | $1.280 | $1.170 | 1,103,800 | |
| $1.240 | +0.040 | +3.3% | $1.200 | $1.460 | $1.200 | 3,063,200 | |
| $1.200 | -0.220 | -15.5% | $1.280 | $1.350 | $1.120 | 3,852,100 | |
| $1.420 | +0.270 | +23.5% | $1.470 | $1.940 | $1.280 | 64,216,200 | |
| $1.150 | +0.481 | +71.9% | $1.140 | $1.750 | $1.010 | 272,903,200 | |
| $0.669 | +0.012 | +1.9% | $0.670 | $0.705 | $0.633 | 43,275,400 | |
| $0.656 | +0.002 | +0.3% | $0.660 | $0.684 | $0.640 | 129,900 | |
| $0.654 | -0.010 | -1.5% | $0.665 | $0.670 | $0.620 | 253,600 |
- Ticker
- NASDAQ:CELZ
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news
Creative Medical Technology Holdings Highlights 93% Patient Response Rate and 65% Reduction in Average Pain Scores in Ultrasome™ Knee Osteoarthritis Study
Oct 20, 2026
Closed $0.755 (+4.3%) on Oct 20, 2026
Creative Medical Technology Holdings, Inc. Expands Ultrasome Intellectual Property Portfolio with New U.S. Provisional Patent Filing
Sep 18, 2026
Closed $0.966 (+10.1%) on Sep 18, 2026
Creative Medical Technology Holdings Successfully Completes Enrollment and Treatment Across Entire FDA-Cleared ADAPT Trial, Including Opioid Cohort, Advancing CELZ-201 / Olastrocel Toward RMAT Evaluation and Phase 3 Planning
Aug 20, 2026
Closed $1.28 (+14.3%) on Aug 20, 2026
Creative Medical Technology Holdings, Inc. Receives Notice of Allowance for New U.S. Patent Covering Exosome-Based Immunotherapy for Type 1 Diabetes, Deepening IP Protection Across Its MyeloCelz™, CELZ-101 and CELZ-201 Diabetes Platforms
Aug 6, 2026
Closed $1.15 (+71.9%) on Aug 6, 2026
Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.5 Million Gross Proceeds
Jun 30, 2026
Closed $1.45 (+79.0%) on Jun 30, 2026
Creative Medical Technology Holdings Expands ADAPT Trial Under New FDA Clearance and Rapidly Advances Toward Phase 3 Planning for Olastrocel in Chronic Lower Back Pain
Jun 22, 2026
Closed $1.93 (-13.5%) on Jun 22, 2026
Creative Medical Technology Holdings, Inc. Advances Project PHOENIX into Nationwide AI Driven Virtual Data Collection Phase for U.S. Veterans Exposed to Burn Pits and Toxic Hazards
Jun 16, 2026
Closed $2.24 (-6.3%) on Jun 16, 2026
Creative Medical Technology Holdings, Inc. Reports Breakthrough 93% Response Rate in Ultrasome™ Knee Osteoarthritis Program, Expanding CELZ-201 Platform into Scalable Cell-Free Regenerative Therapies
Apr 28, 2026
Closed $2.23 (-2.2%) on Apr 28, 2026
Creative Medical Technology Holdings, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 15 in the last 12 months · 99 in all · newest Oct 20, 2026 · oldest 2020
Where Creative Medical Technology Holdings, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:CELZ · Home listing · This page | NASDAQ | United States | USD |
| BOATS:CELZ | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Creative Medical Technology Holdings, Inc.